Investors in Eli Lilly (Symbol: LLY) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

Investing.com -- Fears over the economy are set to remain to the fore amid worries that the Federal Reserve may have left interest rates elevated for too long, allowing them to ...

Investors in Eli Lilly (Symbol: LLY) saw new options begin trading today, for the March 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options ...

View Eli Lilly and Company (LLY) current and estimated P/E ratio data provided by Seeking Alpha.

US stocks mostly gain early Thursday as investors weigh earnings reports. Amazon results are due after the close and monthly ...

Top stock picks for capital appreciation and outperformance, with a focus on profits, dividends, and long-term viability.

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the Nasdaq this year, raising $275 million and $140 million, respectively.

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

NYSE-listed shares of Novo Nordisk surged 4% on Wednesday morning after the Danish pharmaceutical giant posted ...

Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has set terms for an upsized $275M initial public offering. In a recent SEC filing, Metsera (MTSR) said it was ...

The stock market saw surprising gains as investors braced for a wave of earnings reports. By 10:05 A.M. ET, the S&P 500 was up 0.13% to 6,069.47, the Dow was down 0.034% to 44,857.99, and the Nasdaq ...